Urgent.News

What's breaking now, across thousands of outlets.

More in Finance & Markets

Kedrion weighs €2bn debt raise to shareholder dividend

Kedrion Biopharma is exploring a debt financing of around €2bn that could be used in part to fund a dividend payment to its shareholders, according to a report by Bloomberg citing unnamed people…

  • Kedrion Biopharma considering €2bn debt financing
  • Funds could be used for shareholder dividends
  • Talks ongoing with private credit lenders

More from Monday 17 August →